Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein

Weiwei Sheng1, Ming Dong1, Chuanping Chen2

  • 1Department of General Surgery, Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, China.

Oncotarget
|January 24, 2022
PubMed

Insights

This study corrects the article DOI for a previously published paper. The correct DOI is 10.18632/oncotarget.8736.

Area of Science:

  • Scientific publishing
  • Article corrections
  • Digital Object Identifier (DOI)

Context:

  • Ensuring accuracy in scientific literature
  • Maintaining the integrity of research records
  • Proper citation and discoverability of scientific articles

Purpose:

  • To provide the correct Digital Object Identifier (DOI) for a specific scientific article
  • To rectify an error in the previously published citation information
  • To facilitate accurate referencing and access to the research

Summary:

  • The article provides a correction to the Digital Object Identifier (DOI) for a published scientific paper.
  • The correct DOI is 10.18632/oncotarget.8736.
  • This correction ensures that readers and indexing services can accurately locate and cite the article.

Impact:

  • Improved discoverability of the scientific article
  • Enhanced accuracy in academic citations
  • Facilitation of seamless access to research for the scientific community

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K